All Pharma News
Ionis To Webcast HALOS Study Results For ION582 In Angelman Syndrome

Ionis To Webcast HALOS Study Results For ION582 In Angelman Syndrome
PR NEWSWIRE
08 Jul 2024
Share Share
Ionis Announces olezarsen FCS NDA Accepted for Priority Review

Ionis Announces olezarsen FCS NDA Accepted for Priority Review
PR NEWSWIRE
25 Jun 2024
Share Share
Ionis Expands Licensing Agreement With Otsuka For Donidalorsen In Angioedema

Ionis Expands Licensing Agreement With Otsuka For Donidalorsen In Angioedema
PR NEWSWIRE
18 Jun 2024
Share Share
Ionis To Present At TD Cowen Genetic Medicines & RNA Summit

Ionis To Present At TD Cowen Genetic Medicines & RNA Summit
PR NEWSWIRE
17 Jun 2024
Share Share
GSK acquires oligonucleotide drug startup Elsie

GSK acquires oligonucleotide drug startup Elsie
Delilah Alvarado BIOPHARMADIVE
07 Jun 2024
Share Share
Ionis Positive Donidalorsen Data In Hereditary Angioedema

Ionis Positive Donidalorsen Data In Hereditary Angioedema
PR NEWSWIRE
31 May 2024
Share Share
Ionis to hold donidalorsen Phase 3 data webcast

Ionis to hold donidalorsen Phase 3 data webcast
PR NEWSWIRE
28 May 2024
Share Share
Wainua™ Neuro-Ttransform Isa Data: To Be Presented At 2024 Symposium

Wainua™ Neuro-Ttransform Isa Data: To Be Presented At 2024 Symposium
PR NEWSWIRE
23 May 2024
Share Share
Biogen, Ionis to discontinue development of experimental ALS drug

Biogen, Ionis to discontinue development of experimental ALS drug
REUTERS
17 May 2024
Share Share
Ionis Announces Positive ION582 Angelman Syndrome Topline Results

Ionis Announces Positive ION582 Angelman Syndrome Topline Results
PR NEWSWIRE
16 May 2024
Share Share